lawmakers applaud fast-track for psychedelic drug reviews
Digest more
Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.
Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call addiction. We now know that addiction is largely a brain ...
Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and genetic tools, scientists still cannot fully explain why some people get hooked and others walk away. The closer researchers zoom ...
Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline in the function of the prefrontal cortex (PFC), which ...
You’ve likely seen some of the headlines: psychedelics aren’t just for getting high, they’re showing real medical promise. In some fields (like PTSD and addiction), they’re even being heralded as the next frontier of mental health.
Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop cravings even before people trying to quit feel them.
Major scientific discoveries can arise from simple decisions: say, by simply looking where virtually no one else has. Such was the case for Ines Ibañez-Tallon, a research associate professor in the Laboratory of Molecular Biology at The Rockefeller ...
A growing movement claims social media is “addictive,” and lawmakers are treating it as settled science. But the evidence is far less clear, and the rush to litigate and regulate risks turning a debated concept into sweeping policy.